Nureca Limited — Updates, 18-01-2026: General Updates
18-01-2026 | 08:36 pm
18-01-2026 | 08:36 pm
Nureca delivered robust Q3 FY26. Revenue grew 27% YoY to INR 54.0 Cr, EBITDA surged 314% to INR 5.4 Cr, and PAT climbed 233% to INR 3.7 Cr. New products launched, and Dr Trust 360 app users grew. Manufacturing site development is delayed.
No comments yet. Be the first to comment!
